XRCC1 Arg399Gln gene polymorphism and breast cancer risk: A Meta-analysis based on case-control studies

Asian Pacific Journal of Cancer Prevention

Volumn 12, Issue 9, 2011, Pages 2237-2243

  Wu, Kusheng ^a   Su, Daisi ^a   Lin, Kun ^a   Luo, Jiayi ^a   Au, William W ^a  

^a SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

Author keywords

Arg399Gln; Breast cancer; XRCC1 gene polymorphism

Indexed keywords

DNA BINDING PROTEIN; X-RAY REPAIR CROSS COMPLEMENTING PROTEIN 1; XRCC1 PROTEIN;

ALLELE; ARTICLE; BREAST TUMOR; CASE CONTROL STUDY; CONFIDENCE INTERVAL; ETHNIC GROUP; ETHNOLOGY; FEMALE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; HUMAN; META ANALYSIS; RISK; RISK FACTOR;

ALLELES; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CONFIDENCE INTERVALS; DNA-BINDING PROTEINS; ETHNIC GROUPS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; ODDS RATIO; POLYMORPHISM, GENETIC; RISK; RISK FACTORS;

EID: 84866290000     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. Ali MF, Meza JL, Rogan EG, Chakravarti D (2008). sPrevalence of BER gene polymorphisms in sporadic breast cancer. Oncol Rep, 19, 1033-8.
2. BCAC (2006). Commonly studied single-nucleotide polymorphisms and breast cancer: results from the Breast Cancer Association Consortium. J Natl Cancer Inst, 98, 1382-96.
3. Begg CB, Mazumdar M (1994). Operating characteristics of a rank correlation test for publication bias. Biometrics, 50, 1088-101.
4. Brewster AM, Jorgensen TJ, Ruczinski I, et al. (2006). Polymorphisms of the DNA repair genes XPD (Lys751Gln) and XRCC1 (Arg399Gln and Arg194Trp): relationship to breast cancer risk and familial predisposition to breast cancer. Breast Cancer Res Treat, 95, 73-80.
5. Bu D, Tomlinson G, Lewis C, et al. (2006). An intronic polymorphism associated with increased XRCC1 expression, reduced apoptosis and familial breast cancer. Breast Cancer Res Treat, 99, 257-65.
6. Caldecott KW, Aoufouchi S, Johnson P, Shall S (1996). XRCC1 polypeptide interacts with DNA polymerase beta and possibly poly (ADP-ribose) polymerase, and DNA ligase III is a novel molecular 'nick-sensor' in vitro. Nucleic Acids Res, 24, 4387-94.
7. Caldecott KW, McKeown CK, Tucker JD, et al. (1994). An interaction between the mammalian DNA repair protein XRCC1 and DNA ligase III. Mol Cell Biol, 14, 68-76.
8. Cappelli E, Taylor R, Cevasco M, et al. (1997). Involvement of XRCC1 and DNA ligase III gene products in DNA base excision repair. J Biol Chem, 272, 23970-5.
9. Chacko P, Rajan B, Joseph T, et al. (2005). Polymorphisms in DNA repair gene XRCC1 and increased genetic susceptibility to breast cancer. Breast Cancer Res Treat, 89, 15-21.
10. Costa S, Pinto D, Pereira D, et al. (2007). DNA repair polymorphisms might contribute differentially on familial and sporadic breast cancer susceptibility: a study on a Portuguese population. Breast Cancer Res Treat, 103, 209-17.
11. Deligezer U, Dalay N (2004). Association of the XRCC1 gene polymorphisms with cancer risk in Turkish breast cancer patients. Exp Mol Med, 36, 572-5.
12. Duell EJ, Holly EA, Bracci PM, et al. (2002). A population-based study of the Arg399Gln polymorphism in X-ray repair cross- complementing group 1 (XRCC1) and risk of pancreatic adenocarcinoma. Cancer Res, 62, 4630-6.
13. Duell EJ, Millikan RC, Pittman GS, et al. (2001). Polymorphisms in the DNA repair gene XRCC1 and breast cancer. Cancer Epidemiol Biomarkers Prev, 10, 217-22.
14. Duell EJ, Wiencke JK, Cheng TJ, et al. (2000). Polymorphisms in the DNA repair genes XRCC1 and ERCC2 and biomarkers of DNA damage in human blood mononuclear cells. Carcinogenesis, 21, 965-71.
15. Dufloth RM, Costa S, Schmitt F, Zeferino LC (2005). DNA repair gene polymorphisms and susceptibility to familial breast cancer in a group of patients from Campinas, Brazil. Genet Mol Res, 4, 771-82.
16. Egger M, Davey Smith G, Schneider M, Minder C. (1997). Bias in meta-analysis detected by a simple, graphical test. BMJ, 629-34.
17. Figueiredo JC, Knight JA, Briollais L, et al. (2004). Polymorphisms XRCC1-R399Q and XRCC3-T241M and the risk of breast cancer at the Ontario site of the Breast Cancer Family Registry. Cancer Epidemiol Biomarkers Prev, 13, 583-91.
18. Forsti A, Angelini S, Festa F, et al. (2004). Single nucleotide polymorphisms in breast cancer. Oncol Rep, 11, 917-22.
19. Goode EL, Ulrich CM, Potter JD (2002). Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiol Biomarkers Prev, 11, 1513-30.
20. Han J, Hankinson SE, De Vivo I, et al. (2003). A prospective study of XRCC1 haplotypes and their interaction with pl asma carotenoids on breast cancer risk. Cancer Res, 63, 8536-41.
21. Harms C, Salama SA, Sierra-Torres CH, et al. (2004). Polymorphisms in DNA repair genes, chromosome aberrations, and lung cancer. Environ Mol Mutagen, 44, 74-82.
22. Hoeijmakers JH (2001). Genome maintenance mechanisms for preventing cancer. Nature, 411, 366-74.
23. Hsu MS, Yu JC, Wang HW, et al. (2010). Synergistic effects of polymorphisms in DNA repair genes and endogenous estrogen exposure on female breast cancer risk. Ann Surg Oncol, 17, 760-71.
24. Hussien YM, Gharib AF, Awad HA, et al. (2011). Impact of DNA repair genes polymorphism (XPD and XRCC1) on the risk of breast cancer in Egyptian female patients. Mol Biol Rep. (in press).
25. Ioannidis JP, Boffetta P, Little J, et al (2008). Assessment of cumulative evidence on genetic associations: interim guidelines. Int J Epidemiol, 37, 120-32.
26. Jelonek K, Gdowicz-Klosok A, Pietrowska M, et al. (2010). Association between single-nucleotide polymorphisms of selected genes involved in the response to DNA damage and risk of colon, head and neck, and breast cancers in a Polish population. J Appl Genet, 51, 343-52.
27. Jin MJ, Chen K, Zhang SS, et al. (2006). Association of single nucleotide polymorphisms and haplotypes in DNA repair gene XRCC1 with susceptibility of breast cancer. Zhejiang Da Xue Xue Bao Yi Xue Ban, 35, 370-6 (in Chinese).
28. Kim SU, Park SK, Yoo KY, et al. (2002). XRCC1 genetic polymorphism and breast cancer risk. Pharmacogenetics, 12, 335-8.
29. Kipikasova L, Wolaschka T, Bohus P, et al. (2008). Polymorphisms of the XRCC1 and XPD genes and breast cancer risk: a case-control study. Pathol Oncol Res, 14, 131-5.
30. Li H, Ha TC, Tai BC (2009). XRCC1 gene polymorphisms and breast cancer risk in different populations: a meta-analysis. Breast, 18, 183-91.
31. Little J, Bradley L, Bray MS, et al. (2002). Reporting, appraising, and integrating data on genotype prevalence and gene-disease associations. Am J Epidemiol, 156, 300-10.
32. Liu L, Yuan P, Wu C, et al. (2011). A functional -77T>C polymorphism in XRCC1 is associated with risk of breast cancer. Breast Cancer Res Treat, 125, 479-87.
33. Loizidou MA, Michael T, Neuhausen SL, et al. (2008). Genetic polymorphisms in the DNA repair genes XRCC1, XRCC2 and XRCC3 and risk of breast cancer in Cyprus. Breast Cancer Res Treat, 112, 575-9.
34. Lunn RM, Langlois RG, Hsieh LL, et al. (1999). XRCC1 polymorphisms: effects on aflatoxin B1-DNA adducts and glycophorin A variant frequency. Cancer Res, 59, 2557-61.
35. Marsin S, Vidal AE, Sossou M, et al. (2003). Role of XRCC1 in the coordination and stimulation of oxidative DNA damage repair initiated by the DNA glycosylase hOGG1. J Biol Chem, 278, 44068-74.
36. Masson M, Niedergang C, Schreiber V, et al. (1998). XRCC1 is specifically associated with poly(ADP-ribose) polymerase and negatively regulates its activity following DNA damage. Mol Cell Biol, 18, 3563-71.
37. Metsola K, Kataja V, Sillanpaa P, et al. (2005). XRCC1 and XPD genetic polymorphisms, smoking and breast cancer risk in a Finnish case-control study. Breast Cancer Res, 7, R987-97.
38. Mitra AK, Singh N, Singh A, et al. (2008). Association of polymorphisms in base excision repair genes with the risk of breast cancer: a case-control study in North Indian women. Oncol Res, 17, 127-35.
39. Moullan N, Cox DG, Angele S, et al. (2003). Polymorphisms in the DNA repair gene XRCC1, breast cancer risk, and response to radiotherapy. Cancer Epidemiol Biomarkers Prev, 12, 1168-74.
40. Novak DJ, Sabbaghian N, Maillet P, et al. (2009). Analysis of the genes coding for the BRCA1-interacting proteins, RAP80 and Abraxas (CCDC98), in high-risk, non-BRCA1/2, multiethnic breast cancer cases. Breast Cancer Res Treat, 117, 453-9.
41. Pachkowski BF, Winkel S, Kubota Y, et al. (2006). XRCC1 genotype and breast cancer: functional studies and epidemiologic data show interactions between XRCC1 codon 280 His and smoking. Cancer Res, 66, 2860-8.
42. Patel AV, Calle EE, Pavluck AL, et al. (2005). A prospective study of XRCC1 (X-ray cross-complementing group 1) polymorphisms and breast cancer risk. Breast Cancer Res, 7, R1168-73.
43. Saadat M, Kohan L, Omidvari S (2008). Genetic polymorphisms of XRCC1 (codon 399) and susceptibility to breast cancer in Iranian women, a case-control study. Breast Cancer Res Treat, 111, 549-53.
44. Sangrajrang S, Schmezer P, Burkholder I, et al. (2008). Polymorphisms in three base excision repair genes and breast cancer risk in Thai women. Breast Cancer Res Treat, 111, 279-88.
45. Santos RA, Teixeira AC, Mayorano MB, et al. (2010). DNA repair genes XRCC1 and XRCC3 polymorphisms and their relationship with the level of micronuclei in breast cancer patients. Genet Mol Biol, 33, 637-40.
46. Shen J, Gammon MD, Terry MB, et al. (2005). Polymorphisms in XRCC1 modify the association between polycyclic aromatic hydrocarbon-DNA adducts, cigarette smoking, dietary antioxidants, and breast cancer risk. Cancer Epidemiol Biomarkers Prev, 14, 336-42.
47. Shu XO, Cai Q, Gao YT, et al. (2003). A population-based case-control study of the Arg399Gln polymorphism in DNA repair gene XRCC1 and risk of breast cancer. Cancer Epidemiol Biomarkers Prev, 12, 1462-7.
48. Silva SN, Moita R, Azevedo AP, et al. (2007). Menopausal age and XRCC1 gene polymorphisms: role in breast cancer risk. Cancer Detect Prev, 31, 303-9.
49. Smith TR, Levine EA, Freimanis RI, et al. (2008). Polygenic model of DNA repair genetic polymorphisms in human breast cancer risk. Carcinogenesis, 29, 2132-8.
50. Smith TR, Levine EA, Perrier ND, et al. (2003a). DNA-repair genetic polymorphisms and breast cancer risk. Cancer Epidemiol Biomarkers Prev, 12, 1200-4.
51. Smith TR, Miller MS, Lohman K, et al. (2003b). Polymorphisms of XRCC1 and XRCC3 genes and susceptibility to breast cancer. Cancer Lett, 190, 183-90.
52. Sterpone S, Mastellone V, Padua L, et al. (2010). Single-nucleotide polymorphisms in BER and HRR genes, XRCC1 haplotypes and breast cancer risk in Caucasian women. J Cancer Res Clin Oncol, 136, 631-6.
53. Syamala VS, Syamala V, Sreedharan H, et al. (2009). Contribution of XPD (Lys751Gln) and XRCC1 (Arg399Gln) polymorphisms in familial and sporadic breast cancer predisposition and survival: an Indian report. Pathol Oncol Res, 15, 389-97.
54. Thyagarajan B, Anderson KE, Folsom AR, et al. (2006). No association between XRCC1 and XRCC3 gene polymorphisms and breast cancer risk: Iowa Women's Health Study. Cancer Detect Prev, 30, 313-21.
55. Wood RD, Mitchell M, Sgouros J, Lindahl T (2001). Human DNA repair genes. Science, 291, 1284-9.
56. Zhai X, Liu J, Hu Z, et al. (2006). Polymorphisms of ADPRT Val762Ala and XRCC1 Arg399Glu and risk of breast cancer in Chinese women: a case control analysis. Oncol Rep, 15, 247-52.
57. Zhang Y, Newcomb PA, Egan KM, et al. (2006). Genetic polymorphisms in base-excision repair pathway genes and risk of breast cancer. Cancer Epidemiol Biomarkers Prev, 15, 353-8.
58. Zipprich J, Terry MB, Brandt-Rauf P, et al. (2010). XRCC1 polymorphisms and breast cancer risk from the New York Site of the Breast Cancer Family Registry: A family-based case-control study. J Carcinog, 9, 4.